QXL138AM

A First-in-human Phase 1a/1b Study to Evaluate Safety and Tolerability of QXL138AM in Patients With Locally Advanced Un-resectable and/or Metastatic Solid Tumors and Multiple Myeloma

Arms / Cohorts

Experimental, Phase 1a Dose Escalation:Part A1: QXL138AM Dose Escalation in Solid Tumors

Accepting patients

Experimental, Phase 1a Dose Escalation:Part A2: QXL138AM Dose Escalation in Multiple Myeloma

Accepting patients

Experimental, Phase 1b Dose Escalation:Part B1: QXL138AM Dose Expansion in Solid Tumors

Not yet accepting

Experimental, Phase 1b Dose Escalation:Part B2: QXL138AM Dose Expansion in Multiple Myeloma

Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.